Footfalls & Heartbeats Secures Three New Licensing Opportunities

Hot on the heels of signing major deal with global healthcare giant Medi

Kiwi tech start-up, Footfalls & Heartbeats, has secured itself as a technology platform play to be reckoned with, in the rapidly growing smart textile market. And the company isn’t skipping a beat, following the announcement of three new letters of intent signed by global operators.

With a sophisticated governance structure and an adept executive team, Footfalls & Heartbeats is now well positioned for expansion. Given its proven model of securing separate exclusive licenses with leading industrial players for many different and high value applications, Footfalls & Heartbeats is one to watch.

As a key enabling player in the growing billion dollar smart textile market, Footfalls & Heartbeats has gained a reputation for making good on its IP and technology, securing a number of commercial deals this year.

Just three months ago, Footfalls signed its first major, exclusive and ongoing licensing deal with one of the world’s largest medical compression bandage companies, German healthcare giant Medi GmbH & Co. KG (Medi). The innovative smart fabric company now has three letters of intent from additional licensing partners for other applications, demonstrating ongoing commercial interest in the business.

Roland Toder, Managing Director, Business Development and International Licensing, says letters of intent with a clinical bed company, a global technical fabrics company, and a wheelchair seat company have been signed in recent weeks:

“Footfalls & Heartbeats is very much on a roll. The three new letters of intent and key commercial terms come hot on the heels of our ongoing agreement with Medi, and they confirm that we’re offering a sound platform technology play to our licensing partners.”

Footfalls & Heartbeats’ IP has many applications from healthcare and medical uses, to commercial fabrics on public transport to office interiors. The company’s first licensing partner, Medi, operates in over 90 countries, so immediately its technology is reaching a vast audience around the world.

Toder says these diverse target sectors are realising the value of applying Footfalls & Heartbeats’ patented IP to their offerings.

“The letters signal to the smart textile sector – and to the investor market – that we are doing the business and getting our technology and IP applied to sectors that will change the way people interact with products, and how information is used.

“Our sensory fabric monitors change in real time, so you can imagine how many areas and organisations would find that extremely useful for data collection and product improvement. Our IP has applications ranging from detecting pressure areas for hospital bed injury prevention, to monitoring how passengers use public transport through seat use, through to understanding and preventing wheel chair pressure injuries.”

Toder says, “We excel at taking the world-leading ideas from our team, and generating commercial leads and deals that take our IP to market. Lots of start-ups come up with exciting technologies and ideas, but there are far fewer that go out and secure major commercial deals.

“We’ve got a laser sharp focus on executing our strategic plan and closing deals that enable further growth and development and these three letters of intent are the tip of the iceberg when it comes to the activity we have going on in the company, and which we’ll be sharing with the market in the months to come.”

www.footfallsandheartbeats.com